ClinicalTrials.Veeva

Menu

Effect of Basis™ and High Intensity Interval Training (HIIT) on Muscle Metabolism and Exercise Performance

E

Elysium Health

Status and phase

Withdrawn
Phase 1

Conditions

Healthy

Treatments

Dietary Supplement: Placebo oral capsule
Dietary Supplement: NRPT

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04050358
Basis-HIIT

Details and patient eligibility

About

This is a single-center, randomized, placebo-controlled pilot study to evaluate the effects of high intensity interval training (HIIT) and daily administration of BasisTM for 3 weeks, in 18-35 year old males.

The study will consist of a screening visit, baseline visit, followed by treatment and HIIT phase (3 weeks) and a post-supplementation, follow-up visit (this will occur 48 h (or more) after the final HIIT session). Following the screening phase, subjects who meet entry criteria will be randomly assigned to 1 of 2 treatment groups: recommended dose of BasisTM (250 mg Nicotinamide Riboside and 50 mg Pterostilbene) per day or matching-placebo in a 1:1 ratio.

Sex

Male

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18 to 35 year old males
  • Body mass index between 18.5-30 kg.m-2
  • Ability to give informed consent
  • Recreationally active (defined in the present study as exercising once a week or more).

Exclusion criteria

  • Those regularly conducting HIIT or highly trained in endurance events (e.g. triathlete)
  • Currently taking supplements known to affect metabolism (e.g. ibuprofen, stimulants, vitamins, NR)
  • Taking prescribed medication
  • Consuming a vegan diet
  • Consuming a high fat, low carbohydrate diet
  • Habitual consumption of protein and/or dairy supplements (e.g. whey protein)
  • Smokers

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

0 participants in 2 patient groups, including a placebo group

1X dose of NRPT
Active Comparator group
Treatment:
Dietary Supplement: NRPT
Placebo
Placebo Comparator group
Treatment:
Dietary Supplement: Placebo oral capsule

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems